North America Single Use Bioprocessing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)
North America Single Use Bioprocessing Market: by Type (Single-Use Bioreactors, Disposable Mixers, Filtration Devices, Bags & Containers, Tubing, Sampling Systems), Application (Filtration, Cell Culture, Mixing, Storage, Purification, Sampling), Distribution Channels (Direct Sales, Distributors, Online, Retail, Third-Party Vendors, Others), Technology (Stirred-tank, Wave-induced, Centrifugal, Hybrid, Flow-through, Microcarrier-based) Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Last Updated: 31-07-2025 | Format: PDF | Report ID:20445 | Author: Alice
North America Single Use Bioprocessing Market (2025-2035) Industry Overview
The North America Single Use Bioprocessing Market is a rapidly evolving segment of the life sciences industry, leveraging disposable technologies to optimize biopharmaceutical manufacturing. It encompasses a diverse range of products including bioreactors, mixers, filtration devices, bags, tubing, and sampling systems. These systems reduce cross-contamination, improve operational flexibility, and lower capital costs, supporting applications in cell culture, purification, storage, and more. Advancements in single-use technology and demand for efficient, scalable solutions have propelled market growth, with rising investments from pharmaceutical giants and biotechnology startups across the United States, Canada, and Mexico.
Latest Market Dynamics
Key Drivers
Growing demand for biologics and vaccines which require flexible, scalable manufacturing platforms; for example, Thermo Fisher Scientific has increased investments in single-use production sites as biopharmaceutical clients expand capacity for rapid product launches.
Cost efficiency and reduction in operational downtime offered by single-use systems, evidenced by Sartorius AG launching advanced disposable bioreactor solutions catering to midsize and large-scale bioproduction.
Key Trends
Integration of automation and digital monitoring within single-use bioprocessing, seen in new offerings by Danaher Corporation that pair their hardware with data analytics platforms for quality assurance.
A shift toward hybrid processing combinations, with Merck KGaA introducing hybrid solutions blending single-use and stainless-steel components for enhanced operational flexibility.
Key Opportunities
Expansion into new therapeutic areas such as cell and gene therapy, where Eppendorf AG’s single-use systems support lab-to-commercial scale flexibility.
Broader utilization in contract manufacturing organizations (CMOs), illustrated by GE Healthcare’s collaborations with regional CMOs to adopt disposable technologies for shortened project timelines.
Key Challenges
Supply chain constraints and quality concerns with specialized raw materials; companies like Saint-Gobain are investing in local supply solutions to mitigate risk.
Complex validation and qualification processes for single-use components when compared to traditional systems, as highlighted by Parker Hannifin Corporation’s investments in regulatory compliance solutions.
Key Restraints
Concerns about plastic waste and sustainability; for example, Corning Incorporated is developing recycling programs and biodegradable polymers to address environmental impact.
Limitations in scalability for certain large-volume bioprocess applications, driving Kuhner AG’s innovation in large-format disposable bioreactors for commercial deployment.
Single-use bioreactors lead the North America Single Use Bioprocessing Market, accounting for the largest share in 2025 due to their critical role in modern biologic production processes. The demand for high-efficiency, contamination-free systems has driven widespread adoption, especially in commercial and developmental bioproduction. Disposable mixers and filtration devices follow closely, offering streamlined operations with minimal cleaning and turnaround times. Bags & containers, tubing, and sampling systems also contribute significant value, providing enhanced sterility, flexibility, and integrated monitoring for large and small operations alike.
Filtration constitutes the largest application segment in the North America Single Use Bioprocessing Market in 2025, thanks to the critical need for maintaining product purity while preventing contamination. Cell culture and mixing also hold substantial shares, underlining the growing adoption of disposables at early and intermediate stages of bioprocessing workflows. Storage and purification applications benefit from the operational advantages of single-use systems, such as decreased cleaning validation and increased process reproducibility. Sampling solutions, although representing a smaller segment, enable enhanced monitoring and quality controls.
The North America Single Use Bioprocessing Market is projected to grow from $3,450 million in 2020 to $12,670 million by 2035, reflecting rising demand for flexible biomanufacturing infrastructure. The market has demonstrated robust year-over-year expansion, strongly influenced by rapid growth in modalities such as cell and gene therapy production. With biopharma innovation accelerating across the region, investments in disposable solutions have surged, particularly in the US. Growth rates remain high, driven by increasing product launches, strategic partnerships, and continuous advancements in scalability and automation over the forecast period.
Year-on-year growth in the North America Single Use Bioprocessing Market has remained above 10% during the early 2020s, with peak expansion observed around 2024-2027 at approximately 13%-15% as biopharmaceutical manufacturers ramp up investments in disposable technologies. Growth moderates slightly after 2030, stabilizing around 8%-9% as the market matures, driven by replacement demand, expanded product ranges, and regulatory harmonization. This sustained trajectory underscores the market’s vital role in supporting the efficiency and speed-to-market requirements of the life sciences sector.
The United States retains an overwhelming dominance in the North America Single Use Bioprocessing Market in 2025, holding 77% of the regional market share. Its advanced biopharmaceutical ecosystem, along with significant infrastructure investments, fosters rapid adoption. Canada follows, leveraging supportive government policies and growing biomanufacturing clusters to achieve 14%. Mexico, with emerging industry initiatives and a nascent but expanding life sciences sector, captures 9%. The regional distribution highlights the US as the central growth engine, with adjacent markets showing potential for accelerated future uptake.
Thermo Fisher Scientific leads the North America Single Use Bioprocessing Market in 2025, owning 22% of the total market by virtue of their extensive product portfolio and deep integration with biopharma manufacturing. Sartorius AG and Danaher Corporation follow, supported by robust investments in innovation and scalable solutions. Other key players such as Merck KGaA and GE Healthcare round out the competitive landscape, each contributing significantly through advanced R&D and regional partnerships.
Biopharmaceutical companies constitute the largest buying segment in the North America Single Use Bioprocessing Market for 2025, representing 58% of purchases. Contract Manufacturing Organizations (CMOs) make up 24%, driven by their growing adoption of flexible production models. Research institutes, academic labs, and others collectively capture the remaining 18%, reflecting ongoing adoption for research-scale and pilot manufacturing activities. This distribution signals the market’s crucial role in commercial production, alongside growing traction within innovation and research avenues.
June 2024: Thermo Fisher Scientific announced the launch of a new large-scale single-use bioreactor suite designed for commercial biologics production in North America.
July 2024: Sartorius AG formed a strategic partnership with a leading US-based CMO for the deployment of integrated single-use solutions across multiple production sites.
August 2024: Danaher Corporation unveiled an advanced single-use system featuring automated analytics integration for upstream processing applications.
September 2024: Merck KGaA introduced a line of sustainable single-use components made from recyclable and biodegradable polymers to reduce environmental impact.
October 2024: GE Healthcare expanded its regional manufacturing capacity with additional cleanroom capability for disposable bioprocess assemblies in Canada.
Frequently Asked Questions
About the Author
Alice
Senior Research Consultant
Alice is a Senior Research Consultant specializing in market research, industry analysis, and business consulting across Healthcare. Alice brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Alice has helped organizations translate data into actionable growth strategies.
